Alignment Healthcare, Inc. reports developments tied to its Medicare Advantage business for seniors, including health plan membership, revenue growth, adjusted gross profit, adjusted EBITDA and annual guidance. The company operates under the Alignment Health consumer brand and works with local provider partners to deliver coordinated care through a customized care model, a 24/7 concierge care team and the AVA® technology platform.
Recurring updates include quarterly and full-year results, membership outlooks for HMO and PPO contracts, Medicare Advantage operating trends, investor conference presentations and registered offerings involving common stock. News also follows the company's expansion of health plan offerings and national footprint within senior care.
Summary not available.
Alignment Healthcare (ALHC) will report its Q1 2021 financial results on May 17, 2021, post-market. The company focuses on Medicare Advantage, offering technology-enabled, customized health care for seniors and chronically ill patients. The results will be discussed in a conference call at 5 p.m. E.T., accessible to both U.S. and international participants. The conference will also be available as a replay for on-demand listening for up to 12 months at their investor relations website.
Alignment Healthcare announced the closing of its initial public offering on March 30, 2021, of 27,200,000 shares of common stock at $18.00 per share, raising approximately $390.6 million in gross proceeds. The offering included 5,500,000 shares sold by existing stockholders. The funds will be utilized for working capital, general corporate purposes, and to strengthen the balance sheet. Joint book-running managers include Goldman Sachs, Morgan Stanley, and J.P. Morgan. The stock is listed on Nasdaq under the symbol ALHC.
Alignment Healthcare announced the pricing of its initial public offering (IPO) of 27,200,000 shares at $18.00 per share, including 5,500,000 shares from existing stockholders. Underwriters have a 30-day option to purchase an additional 4,080,000 shares. Trading is set to begin on the Nasdaq under the symbol ALHC on March 26, 2021, with the offering closing on March 30, 2021. Proceeds will be used for working capital, corporate growth investments, and debt repayment.